The United States market has shown robust performance, climbing by 2.8% over the past week and up 25% over the last 12 months, with earnings projected to grow by 15% annually in the coming years. In this context, identifying stocks that are potentially undervalued and exhibit insider activity can be a strategic approach for investors seeking opportunities amidst these favorable conditions.
Name | PE | PS | Discount to Fair Value | Value Rating |
---|---|---|---|---|
OptimizeRx | NA | 1.1x | 46.05% | ★★★★★☆ |
Quanex Building Products | 35.9x | 0.9x | 35.94% | ★★★★☆☆ |
Franklin Financial Services | 9.6x | 1.9x | 40.25% | ★★★★☆☆ |
McEwen Mining | 4.1x | 2.1x | 46.42% | ★★★★☆☆ |
ProPetro Holding | NA | 0.6x | 39.21% | ★★★★☆☆ |
German American Bancorp | 14.9x | 4.9x | 45.15% | ★★★☆☆☆ |
First United | 13.6x | 3.1x | 47.40% | ★★★☆☆☆ |
Community West Bancshares | 18.7x | 2.9x | 42.25% | ★★★☆☆☆ |
Delek US Holdings | NA | 0.1x | -61.98% | ★★★☆☆☆ |
Sabre | NA | 0.5x | -81.96% | ★★★☆☆☆ |
Click here to see the full list of 45 stocks from our Undervalued US Small Caps With Insider Buying screener.
We'll examine a selection from our screener results.
Simply Wall St Value Rating: ★★★☆☆☆
Overview: Diversified Healthcare Trust operates a portfolio focused on medical office, life science properties, and senior housing facilities with a market capitalization of $1.22 billion.
Operations: The company generates revenue primarily from its Senior Housing Operating Portfolio (SHOP), followed by its Medical Office and Life Science Portfolio. Over recent periods, the gross profit margin showed a trend of fluctuation, reaching 16.87% in the latest quarter. The cost of goods sold (COGS) constitutes a significant portion of expenses, impacting overall profitability.
PE: -1.4x
Diversified Healthcare Trust, a small company in the healthcare sector, has faced financial challenges with a net loss of US$98.69 million for Q3 2024, widening from US$65.78 million the previous year. Despite sales dipping slightly to US$61.64 million this quarter from last year's US$63.39 million, revenue grew to US$373.64 million from US$356.52 million annually due to increased operational activities. While debt coverage by operating cash flow is weak and funding relies solely on external borrowing, insider confidence was evidenced by recent share purchases within the past year, signaling potential optimism about future performance amidst current fiscal constraints and dividend affirmations of $0.01 per share quarterly suggest continued shareholder engagement despite losses.
Review our historical performance report to gain insights into Diversified Healthcare Trust's's past performance.
Simply Wall St Value Rating: ★★★★☆☆
Overview: Quanex Building Products is a company that manufactures and supplies window and door components, kitchen cabinet components, and other building products with operations primarily in North America and Europe, boasting a market cap of approximately $1.10 billion.
Operations: Quanex Building Products generates revenue primarily from North American Fenestration and European Fenestration, with significant contributions from North American Cabinet Components. The company's cost structure is heavily influenced by the cost of goods sold, which consistently represents a substantial portion of revenue. Over recent periods, the net income margin has shown fluctuations, reaching a high of 7.84% in early 2024 before decreasing to 2.59% by October 2024.
PE: 35.9x
Quanex Building Products, a smaller player in the U.S. market, has seen its sales rise to US$1.28 billion for the year ending October 31, 2024, up from US$1.13 billion previously. However, net income dropped to US$33.06 million from US$82.5 million last year, reflecting tighter profit margins at 2.6% compared to 7.3%. Despite no insider confidence through recent purchases and completed share buybacks of 566,000 shares worth US$12.19 million since December 2021 may suggest management's belief in future potential amidst current financial challenges and reliance on external borrowing for funding.
Learn about Quanex Building Products' historical performance.
Simply Wall St Value Rating: ★★★★☆☆
Overview: ProPetro Holding is a company that provides oilfield services, including hydraulic fracturing and wireline services, with a market capitalization of approximately $1.14 billion.
Operations: Hydraulic fracturing is the primary revenue driver, contributing significantly to total revenues. The company's gross profit margin peaked at 32.18% in June 2023 before experiencing a decline to 26.40% by September 2024.
PE: -6.7x
ProPetro Holding, a small company in the United States, recently expanded its operations by launching ProPWRSM to address rising power demands in the Permian Basin. They secured a contract for electric hydraulic fracturing services and ordered over 110 megawatts of mobile power equipment. Despite reporting a net loss of US$137.07 million for Q3 2024, they completed share repurchases worth US$107.44 million by September 30, signaling confidence in their strategic direction and potential growth prospects.
Gain insights into ProPetro Holding's past trends and performance with our Past report.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGS:DHC NYSE:NX and NYSE:PUMP.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.